1. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010; 5:11. PMID:
20492708.
Article
2. Galanello R, Piras S, Barella S, et al. Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia. Br J Haematol. 2001; 115:926–928. PMID:
11843828.
3. Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A, editors. Guidelines for the clinical management of thalassaemia. 2nd Revised ed. Strovolos, Cyprus: Thalassaemia International Federation;2008.
4. Borgna-Pignatti C, Galanello R. Thalassemias and related disorders: quantitative disorders of hemoglobin synthesis. In : Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, editors. Wintrobe's clinical hematology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins;2004. p. 1319–1365.
5. Tanner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson. 2006; 8:543–547. PMID:
16755844.
Article
6. Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005; 1054:40–47. PMID:
16339650.
Article
7. Queiroz-Andrade M, Blasbalg R, Ortega CD, et al. MR imaging findings of iron overload. Radiographics. 2009; 29:1575–1589. PMID:
19959509.
Article
8. Karimi M, Borzouee M, Mehrabani A, Cohan N. Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. Eur J Haematol. 2009; 82:213–218. PMID:
19077048.
Article
9. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008; 10:42. PMID:
18817553.
Article
10. He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification. Magn Reson Med. 2008; 60:1082–1089. PMID:
18956471.
11. Fragasso A, Ciancio A, Mannarella C, et al. Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias. Eur J Intern Med. 2011; 22:62–65. PMID:
21238896.
Article
12. Wood JC. History and current impact of cardiac magnetic resonance imaging on the management of iron overload. Circulation. 2009; 120:1937–1939. PMID:
19884464.
Article
13. Wood JC. Impact of iron assessment by MRI. Hematology Am Soc Hematol Educ Program. 2011; 2011:443–450. PMID:
22160072.
Article
14. Peng CT, Tsai CH, Wu KH, Hsu CC, Sheng TY. Improvement of cardiac function in thalassemia patients using deferiprone. Tzu Chi Med J. 2007; 19:192–199.
Article
15. Gonzalez MM, Berg RA, Nadkarni VM, et al. Left ventricular systolic function and outcome after in-hospital cardiac arrest. Circulation. 2008; 117:1864–1872. PMID:
18378611.
Article
17. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002; 105:1387–1393. PMID:
11901053.
18. Carpenter JP, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011; 123:1519–1528. PMID:
21444881.
Article
19. Di Tucci AA, Matta G, Deplano S, et al. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica. 2008; 93:1385–1388. PMID:
18603557.
Article
20. Hahalis G, Alexopoulos D, Kremastinos DT, Zoumbos NC. Heart failure in beta-thalassemia syndromes: a decade of progress. Am J Med. 2005; 118:957–967. PMID:
16164878.
21. Bosi G, Crepaz R, Gamberini MR, et al. Left ventricular remodelling, and systolic and diastolic function in young adults with beta thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data. Heart. 2003; 89:762–766. PMID:
12807852.
22. Silvilairat S, Sittiwangkul R, Pongprot Y, Charoenkwan P, Phornphutkul C. Tissue Doppler echocardiography reliably reflects severity of iron overload in pediatric patients with beta thalassemia. Eur J Echocardiogr. 2008; 9:368–372. PMID:
17689292.
23. Shahmohammadi A, Davari PN, Aarabi Y, Meraji M, Tabib A, Mortezaeian H. Echocardiographic assessment of cardiac involvement in patients with thalassemia major: evidence of abnormal relaxation pattern of the left ventricle in children and young patients. Iran Heart J. 2006; 7:31–36.
24. Finazzo M, Midiri M, D'Angelo P, et al. The heart of the patient with beta thalassemia major Study with magnetic resonance. Radiol Med. 1998; 96:462–465. PMID:
10051869.
25. Yaprak I, Aksit S, Ozturk C, Bakiler AR, Dorak C, Turker M. Left ventricular diastolic abnormalities in children with beta-thalassemia major: a Doppler echocardiographic study. Turk J Pediatr. 1998; 40:201–209. PMID:
9677725.
26. Mazza P, Giua R, De Marco S, et al. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver. Haematologica. 1995; 80:398–404. PMID:
8566878.
27. Bayraktaroglu S, Aydinok Y, Yildiz D, Uluer H, Savas R, Alper H. The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients. Diagn Interv Radiol. 2011; 17:346–351. PMID:
21647857.
28. Pennell DJ. T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci. 2005; 1054:373–378. PMID:
16339685.
Article
29. Kremastinos DT, Farmakis D, Aessopos A, et al. Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail. 2010; 3:451–458. PMID:
20484195.
30. Ozbek O, Acar K, Kayrak M, et al. Relationship between color M-mode echocardiography flow propagation and cardiac iron load on MRI in patients with thalassemia major. Diagn Interv Radiol. 2012; 18:208–214. PMID:
22006577.